Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about 5/MeO/DMT

Recent news which mentions 5/MeO/DMT

Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
Tickers NEWS
Tags Tommaso Barba Benzinga Dr David Erritzoe
From Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
Tickers NEWS
Tags Benzinga Market News Cannabis
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Tickers ATAI NEWS
Tags News Psychedelics Research ATAI
From Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Tickers GHRS NEWS
Tags Management News Benzinga
From Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
Tickers ATAI GHRS NEWS
Tags Markets ATAI News
From Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
Tickers GHRS
Tags Market News Cannabis Markets
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Tickers GHRS
Tags Psychedelics 5/MeO/DMT News
From Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
Tickers GHRS
Tags News Management Markets
From Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
Tags Management Trauma Survivors News
From Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
Tags Interview News Management
From Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
Tickers GHRS
Tags Psychedelic/Assisted Therapies GHRS Benzinga
From Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
Tags Biotech 5/MeO/DMT Psychedelics
From Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
Tags Beckley Psytech alcohol use disorder Psychedelics
From Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
Tickers GHRS PHRRF
Tags Small Cap 5/MeO/DMT Psychedelics/Assisted Therapy
From Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
Tickers BMNDF
Tags Next/Generation Psychedelics Psychedelics 5/MeO/DMT
From Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
Tags Benzinga Treatment Resistant Depression Market News
From Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
Tags Psychedelics 5/MeO/DMT Global
From Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
Tags Beckley Psytech Psychedelics 5/MeO/DMT
From Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
Tags Cannabis Financing Market News
From Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
Tags Benzinga Prolonged Grief Markets
From Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
Tickers BMNDF
Tags 5/MeO/DMT BMNDF News
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Tickers BMNDF
Tags News Alejandro Antalich BMNDF
From Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
Tickers DMT PSYBF TRUFF
Tags DMT TRUFF Markets
From Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
Tickers GHRS
Tags 5/MeO/DMT Small Cap Psychedelics
From Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
Tickers DMT
Tags contributors Psychedelic Retreats Benzinga
From Benzinga
5 Psychedelics For Mental Health
Tags Benzinga contributors Cannabis
From Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
Tags Benzinga Market News Cannabis
From Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
Tickers DMT
Tags psychedelics Ayahuasca 5/MeO/DMT
From Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
Tickers GHRS
Tags 5/MeO/DMT Biotech Small Cap
From Benzinga
Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying
Tickers GHRS
Tags Benzinga MIke Tyson GHRS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.